TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accom...(son@torreypinestherapeutics.com cjohnson...),Health
Navigation Links
TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments
Date:5/13/2008
son@torreypinestherapeutics.com">cjohnson@torreypinestherapeutics.com david.schull@russopartners.com
Investor Contact:
Rhonda Chiger
Rx Communications
917-322-2569
(Tables Follow)
TorreyPines Therapeutics, Inc.
Condensed Consolidated Balance Sheets
(in thousands)
March 31, December 31,
2008 2007
(Unaudited)
Assets
Current assets
Cash and cash equivalents $ 25,665 $ 32,500
Prepaid expenses and other current assets 543 835
Total current assets 26,208 33,335
Long-term assets 5,846 5,317
Total assets $ 32,054 $ 38,652
Liabilities and stockholders' equity
Current liabilities $ 8,142 $ 9,036
Debt and other long-term liabilities 47 973
Deferred revenue 900 2,183
Total liabilities 9,089 12,192
Total stockholders' equity 22,965 26,460
Total liabilities and stockholders' equity $ 32,054 $ 38,652
TorreyPines Therapeutics, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(Unaudited)
Three
'/>"/>
| SOURCE TorreyPines Therapeutics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. TorreyPines Therapeutics to Present at the JMP Securities Healthcare Focus Conference
2. TorreyPines Therapeutics to Present at BMO Capital Markets Focus on Healthcare Conference
3. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
4. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
5. Prime Therapeutics Receives TIPPS Certification
6. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
7. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
8. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
9. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
10. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
11. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
Post Your Comments:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2[0] Cytiva's one45 Software Rebrands Healthcare Education Administration Products[0] Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events[0] New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation[0] Women's Alcohol Use Tied to Delayed Childbearing
...published in the Journal of Vertebral Subluxation ...ay offer significant benefits //to children suffer...research was conducted by Swiss chiropractor Yanni...ropractic Pediatric Association, who specializes i...
...h finding indicates that patients who were affecte...pse of multiple sclerosis (MS). Multiple Sclerosis...sheath that covers the nerve fibres. // Jorge Corr...ea Institute for Neurological Research in Buenos A...
...ered the fray of painkillers, especially the likes...relieve muscle soreness after a heavy work out or ...ine //equivalent of two cups of coffee, consumed b... by 50%. In the words of researcher Patrick O'Con...
... strain brought havoc to human community by killin...strain of virus was highly lethal and the affected...rein the defense mechanism of the body itself prov...cted. American researchers reconstructed this vir...
Other Medicine News:Health News:Chiropractic Care Helps Children With Learning Disorders and Dyslexia 2Health News:Chiropractic Care Helps Children With Learning Disorders and Dyslexia 3Health News:Work-outs, Not So Much of a ‘pain’ With Caffei 2(Date:8/20/2008)...wire-USNewswire/ -- Graduated compression,stocking...mbosis (DVT) in,hospitalized patients, are often i...tentially-deadly blood clots, according to researc...indings appear in the September issue of the Ameri... increased risk for blood clots after surgery,beca...
(Date:8/20/2008).../- BioVex Inc, a biotechnology,compan...and the prevention,of infectious disease, today an...egulatory Agency (MHRA) has accepted BioVex,s Clin...al study testing the safety and,immunogenicity of ...herpes,ImmunoVEX HSV2., ImmunoVEX HSV2 is a nove...
(Date:8/19/2008)...- Addrenex Pharmaceuticals (, http://... this month to,further its goal of identifying and...e over the next 18 months., The fast-paced timeli...mpany,s recent successes in developing two new dru...y disorder and CloniBID for hypertension,over the...
(Date:8/19/2008)...ewswire-FirstCall/ -- Vical Incorporated,(Nasdaq: ...ith the Karolinska,Institutet (KI), a leading Euro... for Infectious Disease Control (SMI), a governmen...) adjuvant with the Biojector(R),2000 needle-free ....,OTCBB: BJCT) for a multivalent preventive DNA v...
Breaking Medicine Technology:Dallas Researchers Find Compression Stockings Improperly Used 2BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Cleveland Clinic Press Releases Book About a Surgeons Mission to Perform the Worlds First Full Face Transplant 11690 1Cleveland Clinic Press Releases Book About a Surgeons Mission to Perform the Worlds First Full Face Transplant 11690 2Lab on a chip mimics brain chemistry 11687 1Lab on a chip mimics brain chemistry 11687 2Chicago Tribune Does Story on Canine Cancer Morris Animal Foundation 28MAF 29 Effort to Find a Cure MAF Can Provide Information Local Angles for 11682 1PeriCor Therapeutics Appoints K Tucker Andersen to Board of Directors 3231 1PeriCor Therapeutics Appoints K Tucker Andersen to Board of Directors 3231 2[0] Dallas Researchers Find Compression Stockings Improperly Used[0] BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes[0] Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation[0] Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
...ALTO, Calif., March 14, 2007 /PRNewswire-FirstCall...e Journal of the of,Cardiology (JACC) has publishe...ROLE) program, which showed long-term therapy with...o be safe and well,tolerated in patients with chro... clinical trials, and enrolled in the ROLE,program...
...EGO--(BUSINESS WIRE)--Mar 14, 2007 - Sequenom, Inc...Y(R) technology and,iPLEX(TM) assay were used by l...itutions and, in independent studies, significantl...nd drug-resistant,malaria. Results from several of... peer-reviewed journals as follows:, -- In "High-T...
Other Medicine Technology:JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 2JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 3JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 4Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 2Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 3Latex agglutination inhibition slide test for the qualitative detection of hCG in urine.
Indirect hemagglutination test for the qualitative and quantitative determination of antibodies to Toxoplasma gondii in serum.
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood.
Color-enhanced slide agglutination test for the rapid qualitative and semi-quantitative detection of antistreptolysin O.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |